2F: Bridging Science and Market: Commercial Pathways for Biomaterials

Date: Wednesday, March 25, 2026
Time: 3:45 PM to 5:15 PM
Room: Hanover FG
Session Type: Concurrent Session 2

Description

Post-market commercialization pathways for advanced biomaterial technologies
How biomaterial biocompatibility shapes clinical performance and long-term commercial value
Lessons learned in scalable manufacturing, quality control, validation, analytical troubleshooting, failure analysis, and reproducibility

  • 3:45 PM. 84. Commercializing a Class III Medical Device: Lessons Learned with AeroVeil.Lauren Costella, ME1, Kate Johnson1, Christopher Tison, PhD1 1Luna Labs USA

  • 4:00 PM. 85. Commercialization of Polymeric Heart Valve Technology: Clinical Translation and Market Entry of a Surgical Mitral Valve.Ryan Stanfield, PhD1, Morteza Gharib, PhD2, David Grainger, PhD1, Kaushal Pandey, MS, MD3, Isaac George, MD4 1University of Utah, 2California Institute of Technology, 3PD Hinduja Hospital, 4Columbia University

  • 4:15 PM. 86. Hybrid Fiber Meshes for Soft Tissue Reinforcement, Repair, and Regeneration in Breast Reconstruction.Shatil Shahriar1, Jingwei Xie1 1University of Nebraska Medical Center

  • 4:30 PM. 87. Failure Analysis of Hydrogels: Case Studies in the Biomedical Space.Abigail Oelker1, Mike Kratochvil1, Naomi Clayman1, Jessica Vargas1 1Exponent

  • 4:45 PM. 88. Innovative Silicone Rubber Compositions with Anti-Biofilm Characteristics for Preventing Medical Device Infections.David Vachon, Ph.D.1, Mark Vachon, B.S.1 1IASIS Molecular Sciences, Inc.

  • 5:00 PM. 89. Standardized Procedures and Process Monitoring Enable Scalable, Reproducible Polymer Nanoparticle Production.Kenneth Sims, PhD1, Emma Schmitz, BS1, Dean Constantine, BS1, Sam Farrar, MS1, Phil Denen, BS1, Pong Thongsavanh, BS1, Ashlee Colbert, PhD1, Andrea McCue, PhD1, Danielle Huk, PhD1, Gabe Meister, PhD1 1Battelle Memorial Institute